Friday, June 05, 2020

New Psychedelic Stocks added to Investor Ideas Directories (CSE: $TRIP.C) (CSE: $SHRM.C) (OTC: $EHVVF) (OTC: $MMEDF) (TSXV: $NUMI.V)


New Psychedelic Stocks added to Investor Ideas Directories (CSE: $TRIP.C) (CSE: $SHRM.C) (OTC: $EHVVF) (OTC: $MMEDF) (TSXV: $NUMI.V)

Also new stocks in cannabis and mining











Point Roberts WA, Delta BC, June 5, 2020 – (Investorideas.com Newswire) Investorideas.com, a global news source and leading investor resource announces its weekly roundup of stocks added to its global stock directories, including psychedelic, cannabis and mining.


A new section following stocks in the psychedelic/ psilocybin sector has been added to the cannabis stocks list.  See the complete list here:

The latest cannabis and mining stocks are listed on Canadian Exchanges – CSE and TSX Venture, with the cannabis company operating in the US and mining companies operating in both Canada and Peru.

New Stocks added to Psychedlics on Cannabis stocks directory
Red Light Holland Corp. (CSE:TRIP) business revolves around the production, growth and sale (through existing Smart Shops operators and an advanced e-commerce platform) of a premium brand of magic truffles to the legal, recreational market within the Netherlands, in accordance with the highest standards, in compliance with all applicable laws.

Champignon Brands (CSE:SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics, and adaptogenic delivery platforms for nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (PTSD), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami's Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability as its medicinal mushroom-infused SKUs are organic, non-GMO, and vegan certified.

EHave Inc (OTC:EHVVF) is a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients. Our primary focus is on improving the standard care in therapeutics to prevent or treat brain disorders or diseases through the use of digital therapeutics, psychedelics, independently or together, with medications, devices, and other therapies to optimize patient care and health outcomes meeting privacy and HIPAA & GDPR Compliant. Our main product is the Ehave Dashboard which is a mental health informatics platform that allows clinicians to make objective and intelligent decisions through data insight using Blockchain technology. The Ehave dashboard offers Offline Encrypted Digital Records Empowering Healthcare providers and patients and it's a powerful machine learning and artificial intelligence platform using artificial intelligence to extract deep insights from audio, video and text to improve research with a growing set of advanced tools and applications developed by Ehave and its leading partners. This empowers patients, healthcare providers, and payers to address a wide range of conditions through high quality, safe, and effective data-driven involvement with intelligent and accessible tools.

MindMedicine Inc (NEO: MMEDOTC:MMEDF) is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines to improve health, promote wellness and alleviate suffering. The company's immediate priority is to address the opioid crisis by developing a non-hallucinogenic version of the psychedelic ibogaine. In addition, the company has established a microdosing division to conduct clinical trials of LSD microdosing for adult ADHD. The MindMed executive team brings extensive biopharmaceutical industry experience to this ground-breaking approach to the development of next-generation psychedelic medicines.

Numinus Wellness Inc (TSXV:NUMI) is a Vancouver -based health care company helping to support the universal desire to heal and be well. Through its wholly-owned subsidiary Salvation Botanicals, Numinus has a Health Canada cannabis testing licence that allows the company to test and analyze cannabis products from licensed producers. In addition, it is a late-stage applicant to receive a Health Canada standard processing licence to produce cannabis products. Numinus, through the same subsidiary, also has a dealer's licence which allows the company to test, possess, buy and sell MDMA, psilocybin, psilocin, DMT and mescaline. It is seeking to expand the licence to include activities such as import/export, testing and R&D. The expanded licence will allow Numinus to support the growing number of studies on the potential benefits of psychedelic therapies through research projects, product development, and the supply and distribution of these substances. Numinus Wellness is dedicated to therapies that enhance and supplement existing options for people wanting lasting physical, mental and emotional health — with psychedelic treatments at its core when approved for therapeutic and research use. Psychedelics will be part of this offering but will only be available for treatment once approved by regulators and governing bodies — a process Numinus is helping to support.

New Stocks added to Cannabis stocks directory
Sweet Earth Holdings Corporation (CSE:SE) is a vertically integrated and award-winning company focused on hemp production and CBD related products.  A member of the American National Hemp Association and Leaping Bunny accredited, the Company maintains a complete “farm to shelf” platform.  The Company’s American and European farms focus on pure organic hemp growing while production specializes on high-end CBD products that can be purchased on its website and distributors in the United States.

New Stocks added to Mining stocks directory
Edgemont Gold Corp. (CSE:EDGM) is focused entirely on gold exploration in Canada. It is currently actively exploring the Dungate copper/gold porphyry project located 6 km south of Houston in the Omenica Mining Division of northern British Columbia.

Great Thunder Gold Corp. (CSE:GTG) is a Canadian mineral exploration company with projects focused on the Fenelon Gold Camp, along the Detour gold trend in Quebec. The Company’s experienced leadership team is centered around efficiency, asset quality, integrity, and environmental & community responsibility.

Lida Resources Inc. (CSE:LID) is an independent, Canadian-based, internationally focused mining company and, through its subsidiaries in Peru, owns and operates the San Vicente Property

Clean Air Metals Inc. (TSXV:AIR) is a Canadian based platinum and palladium exploration company. The company is focused on advancing its flagship Thunder Bay North and Escape Lake projects which are located in the Thunder Bay region of Ontario.

The directories are not meant as recommendations but as a research tool to discover opportunities and trading ideas in a particular sector.

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news and press releases, research and our own original financial content. We were one of the first retail investor sites to cover renewable energy and cleantech stocks at investorideas.com and our domain Renewableenergystocks.com. We were also one of the most well- known and cited defense stock sites, featuring our domain Homelanddefensestocks.com at its peak.
We follow the money for investors as sector sentiment shifts and technology disrupts. Our mission is to provide investor ideas with breaking news, resources, industry articles and interviews with leading experts.      

Learn about investing in stocks and sector trends with our news alerts, articles,  podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea's original branded content includes the following podcasts and columns: Crypto CornerPlay by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate ChangeExploring Mining and the AI Eye.

Public companies within the sectors we cover use our news and content services to tell their story to interested investors. Paid for content is disclosed.  

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

Learn more about our news, PR and social media services at Investorideas.com

Follow us on Twitter https://twitter.com/Investorideas
Download our Mobile App for iPhone and Android  


Contact Investorideas.com
800 665 0411





VIDEO: President SinglePoint Inc. (OTCQB: $SING) Discusses Online Solar Purchasing and Expansion of 1606 Hemp

VIDEO: President SinglePoint Inc. (OTCQB: $SING) Discusses Online Solar Purchasing and Expansion of 1606 Hemp


Phoenix, Arizona - June 5, 2020 (Investorideas.com Newswire) SinglePoint, Inc. (OTCQB: SING) President joins MoneyTV to discuss how the company is implementing an online solar purchasing platform to streamline the process for customers looking to purchase solar. The interview also overviews the expansion of the company's 1606 Hemp brand, now sold in over 400 stores.


Cannot view this video? Visit: https://www.youtube.com/watch?v=wCZayTlr9nM


About SinglePoint, Inc.
Founded in 2011 SinglePoint, Inc (SING) invests in and acquires brands and companies that will benefit from injection of growth capital and the sales and marketing expertise of SinglePoint. The company portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multinational brand.

Connect on social media at:
For more information visit: www.SinglePoint.com

Forward-Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the Company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements.
Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.

Corporate Communication
SinglePoint Inc.
888-OTC-SING
investors@SinglePoint.com
SinglePoint.com

SinglePoint (SING) is a featured stock on Investorideas.com

More info on SING at Investorideas.com Visit: https://www.investorideas.com/CO/SING/


Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. For Disclosure purposes SinglePoint Inc (OTCQB: SING) is a paid  annual news and social media company on Investorideas.com.  More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp and https://www.investorideas.com/About/News/Clientspecifics.asp . Learn more about our prices for publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.



qTerm - an intelligent human vitals device

GBT Technologies (OTC: $GTCH) VIDEO: qTerm - an intelligent human vitals device; #ArtificialIntelligence


Thursday, June 04, 2020

Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 423 (OTC: $CSUI) (CSE: $IPOT.C) (OTC: $OWPC)(TSX: $VLNS.TO) (CSE: $HOLL.C)


Investor Ideas #Potcasts, #Cannabis News and #Stocks on the Move; Episode 423 (OTC: $CSUI) (CSE: $IPOT.C) (OTC: $OWPC)(TSX: $VLNS.TO) (CSE: $HOLL.C)



Delta, Kelowna, BC, June 4, 2020 (Investorideas.com Newswire) www.Investorideas.com, a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, www.potcasts.ca  release today’s podcast edition of  cannabis news and stocks to watch plus insight from thought leaders and experts.

Listen to the podcast:




Today’s podcast overview/transcript:

Good afternoon and welcome to another episode of Investorideas.com "Potcast" featuring cannabis news, stocks to watch as well as insights from thought leaders and experts.

Today’s podcast is sponsored by Cannabis Suisse Corp. (OTC: CSUI)a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.

The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.

In today’s podcast we will be looking at a few public company announcements.

Isracann Biosciences Inc.  (CSE: IPOT) (OTC: ISCNFannounced their support of the recent government approval permitting the export of cannabis for sale to foreign medicinal markets.

On May 13, 2020, the Israeli Ministry of Economy signed a Free Export Order for medical cannabis products. The order allows the government to implement a medical cannabis decision that was previously signed in 2019. The order was announced to go into effect 30 days from the signing, at which time licensed producers of medical cannabis in Israel will be able to apply for an export permit to ship product to international markets. Accordingly, Isracann has tasked its regional consultants with ensuring applications for an export permit will be made as soon as possible.

As reported by Israel’s Globes Business News, the Ministry of Health stated it will permit exports while ensuring adequate supplies for medical cannabis in the Israeli market. During the second half of 2019, after the Health Ministry's new medical cannabis reform came into effect, the tightened medical cannabis manufacturing and processing standards proved complex for many producers, while at the same time making it easier for patients to obtain licensed access creating a gap in supply. The media outlet further reported that the Ministry of Economy has announced that revenue from medical cannabis exports is expected to reach hundreds of millions of dollars each year. In the sector, it is estimated that if the country leverages early approval for exports, a more significant place could be taken in the global market.

Isracann CEO Darryl Jones notes, “As we have noted previously, supply in both the domestic and European markets is lagging behind demand, especially in Europe as more countries work on less restrictive regulations. Our timely ability to jump into the gap will be a great opportunity for Isracann. Additionally, our marketing strategy aims to leverage Israeli-branded products as fundamentally superior due to the unique environment and advanced agronomics Israel offers. We look forward to working with our consultants and the Ministry to ensure we are ready to apply for export permitting as soon as the application process is clarified.”

The Company also announced today that Mr. Matt Chatterton has been promoted from his role as VP, Operations to the position of Chief Operating Officer. His proven background in manufacturing including project and facility management, logistics, supply side processes and procedures has been utilized extensively since joining the Company. Mr. Chatterton has fully engaged with every aspect of the operation within Israel. His intimate knowledge and relationships across the organizational structure and understanding of the Company’s goals will continue to prove invaluable as commercialization advances.

“I am very grateful for this vote of confidence and the latitude it provides,” Mr. Chatterton comments. “As we move ahead into commercialization, I am confident that our team can quickly advance towards revenue generation and sustainable growth.”

The Company wishes to acknowledge and thank Mr. Israel Moseson who steps down from his role as COO. As a founding member of Isracann, he was instrumental in the early stage growth of the business. We sincerely wish him well in his future endeavors.

One World Pharma Inc. (OTC: OWPCannounced that effective immediately, NBA legend, international entrepreneur and philanthropist Isiah Thomas has been appointed as its CEO and Vice-Chairman of the Board of Directors. Mr. Thomas will replace founder and CEO Craig Ellins who is retiring.

Isiah Thomas, while forever known for his Hall of Fame career as a 12-time NBA All Star, two-time NBA champion, and inclusion as one of the 50 Greatest Players in NBA History, is an accomplished and highly regarded international business executive and investor with a portfolio of companies he has developed via Isiah International Inc. Mr. Thomas has previously served on the Chicago Stock Exchange’s Board of Governors, was a co-founder of the NBA’s Toronto Raptors, Popcorn Indiana, and is a member of the Board of Get-in Chicago, an organization focused on preventing gang violence in Chicago, since 2013.

His business interests include sports and entertainment, real estate, waste management, his cannabis and CBD products company, VESL Oils, and more. Notably, Mr. Thomas has developed a highly successful champagne business with Cheurlin Champagnes, where he has cultivated an excellent relationship with both the grower, employees and the French government. Mr. Thomas now uniquely owns genetics for the grapes produced for the champagne and has perfected an international import/export system for international distribution of the product.

Mr. Thomas inherits the reins of an ascendant international hemp and cannabis company which under Mr. Ellins’ leadership has seen significant development and progress, including the establishment of highly scalable farm and production facilities in Colombia, a portfolio of fully registered elite and government approved genetic strains, and a state sanctioned THC quota.

The Board of Directors is grateful to Mr. Ellins and thanks him for his innovation, dedication, and determination.

“We are elated to welcome Isiah Thomas to the One World Pharma leadership team and to have him continue and expand upon the successes of Craig Ellins,” stated Dr. Kenneth Perego, Executive Chairman of One World Pharma. “Mr. Thomas is the ideal person to lead us in this new phase as we commence commercial sales and revenues, lending to our cause his international business experience, myriad relationships, and commitment to winning.”
“It is truly an honor to work with Mr. Thomas on the One World Pharma opportunity and to leverage his experience in such similar verticals to the benefit of the Company, its shareholders and our indigenous partners in Colombia,” added Brian Moore, President, One World Pharma.

“I am honored to join One World Pharma and its excellent team.  It is a company that is leading the way in innovation in the hemp and cannabis industry,” said Isiah Thomas, CEO and Vice-Chairman. “The company’s deep commitment to excellence in their products and for its customers positions us well to continue to grow as an international leader in the industry. Its  recognition for its humanitarian efforts validates its mission as a socially conscious company in a true partnership with the indigenous people.”

The Valens Company (TSX: VLNS) (OTCQX: VLNCF) announced a custom manufacturing agreement with TREC Brands Inc., a cannabis brand house with a mission of doing good.

Under the agreement between The Valens Company and TREC Brands, The Valens Company will manufacture vape pens across three existing TREC brands; Thumbs Up Brand, WINK, and Blissed, with the potential to later produce other innovative products. TREC has already launched a successful line of tinctures, flower, and pre-rolls, but through this partnership, vape pens will be introduced as a new product format across its current brand portfolio. The TREC Agreement follows a royalty-based payment structure.

TREC's mission is to build socially conscious, purposeful brands with commitments to initiatives that positively impact Canadian communities, the planet, and society as a whole. Each brand in their portfolio has a distinct mission that reflects the core values of the brand house:
     WINK curates unique products and partners with local designers to collaborate on accessories. The brand donates 10% of profits to advance local communities with a focus on progressing culture in fashion, art and music.
     Blissed strives to empower women to shed stigma and live happier, healthier and more authentic existences through educational content, community building and purposefully designed products.
     Thumbs Up Brand aims to deliver high quality cannabis at a fair price to the grower and the consumer.

The execution of the TREC Agreement further solidifies the strength in The Valens Company's customized manufacturing platform that both Licensed Producers and CPG partners utilize to launch products and further their brands in the evolving Canadian market. The Company remains focused on its further development into a leading manufacturer of cannabinoid-based products and continues to broaden its customer product platform from its existing offering of capsules, tinctures, sprays, vapes, beverages, concentrates, distillate, isolate, and SōRSE by Valens emulsion, and expects to also include topicals and edibles in the near to medium term. With this platform, The Valens Company leads the industry as a one-stop-shop and manufacturer of high quality oil-based product formats.

"Through this partnership, The Valens Company and TREC will thoughtfully bring to market high-quality, bespoke products while putting the unique needs of Canadian consumers at the forefront of product development," said Tyler Robson, CEO of The Valens Company. "As Cannabis 2.0 continues to allow for exciting new products and brands to hit shelves in Canada, we are excited to develop products in partnership with authentic, community-centric brands such as those in the TREC portfolio." 

"With The Valens Company's capabilities and expertise to provide customized products to suit each of our brands, we are confident that we are delivering the best possible products to our consumers with a company who values community-level engagement as much as we do," said Trang Trinh, Founding Director and CEO of TREC Brands.

Hollister Biosciences Inc. (CSE: HOLL) (OTC: HSTRFannounced that the Company's 100% owned subsidiary, AlphaMind Brands Inc. plans to launch medicinal mushroom based capsule and powder product lines.

The initial product line will consist of a blended and bottled powder and capsule consisting of powdered cordyceps, lion's mane, oyster, reishi and shiitake medicinal mushroom varietals.  The formulations for both products are unique and developed through research driven initiatives.  The health benefits that the capsules and powder intend to provide include but are not limited to anti-inflammatory, antioxidant, anti-aging, anti-microbial and immune system support.

Raw materials for the product line have arrived at Alphamind's manufacturing partner, Kirkman and have been sent off for third party testing.  Once the ingredients are approved, AlphaMind anticipates production can begin by mid-June with the aim of having the product line in the market by mid-July 2020.

Dr. Nikos Apostolopoulos, CSO of AlphaMind shared, "Our AlphaMind five mushroom blend will be a game changer for both athletes and non-athletes alike. This ethically sourced and organically grown blend provides potent antioxidants, and anti-inflammatory responses, helping to improve and maximize performance as well as daily activities."


Once again, today’s podcast was sponsored by Cannabis Suisse Corp. (OTC: CSUI)a research & development company licensed under Swiss Cannabis and tobacco regulations to cultivate and sell cannabis. The Company's facilities for producing cannabis are based in Zurich.
The Company grows high quality, organic cannabis with sustainable, all-natural principles. Cannabis Suisse products are laboratory tested to ensure the end users have access to a standardized, safe and consistent product.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the
Investorideas.com website and this podcast is not an
ucts or services or securities. Investors are reminded all investment involves risk and possible loss of investment   

Learn more about our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp


To hear more Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com podcasts are also available on iTunes,  Spotify, Google Play Music, Stitcher, Spreaker,   YouTube via Spreaker,  iHeartradio and Tunein.

Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

About Investorideas.com - News that Inspires Big Investing Ideas
Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: CSUI is a paid news and social media sock on investor ideas. More disclaimer info:
https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire
https://www.investorideas.com/News-Upload/ and tickertagstocknews.com
Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy:

Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.


Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


  





Get more Cannabis Stock Investor Ideas – news, articles, podcasts and stock directory

The #AIEye: #AI-Startup Cowbell Cyber Partners with FICO (NYSE: $FICO) and NICE (NasdaqGS: $NICE) Actimize to Acquire Guardian Analytics



The #AIEye: #AI-Startup Cowbell Cyber Partners with FICO (NYSE: $FICO) and NICE (NasdaqGS: $NICE) Actimize to Acquire Guardian Analytics

Global AI Market to Reach $40.74 Billion in 2020 – Driven by COVID-Related Demand



Point Roberts WA, Vancouver BC – June 4, 2020  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of  The AI Eye-  watching stock news, deal tracker and advancements in artificial intelligence.

Listen to today’s podcast:



Today’s Column- The AI Eye- Watching stock news, deal tracker and advancements in artificial intelligence

Stocks discussed: (NYSE:FICO) (NasdaqGS:NICE)

AI-powered cyber insurance startup Cowbell Cyber has partnered with Fair Isaac Corporation (NYSE:FICO) to “add the FICO Cyber Risk Score to Cowbell Cyber's multivariate risk rating factors, Cowbell Factors.” This will enable “cyber insurance agents to expedite the delivery of standalone cyber policies tailored to the unique coverage needs of all SMBs.” Julie May, Vice President of Cybersecurity Solutions at FICO, said:

"FICO's Cyber Risk Score provides underwriting teams with a clear and accurate measure of the cyber risk of an organization. We are excited to strategically partner with Cowbell Cyber and its team to deliver a differentiated cyber offering to the SMB marketplace."


NICE Actimize, the Autonomous Financial Crime Management subsidiary of NICE Ltd. (NasdaqGS:NICE), has entered a definitive agreement to acquire AI cloud-based financial crime risk management solution provider Guardian Analytics. Craig Costigan, NICE Actimize CEO, explained:

"Today, NICE Actimize is taking a significant step forward in advancing the future of managing financial crime risk. With criminals seeking to exploit the current environment, we need to make sure financial institutions and consumers are protected in a way that’s cost-effective and intuitive. The acquisition of Guardian Analytics brings together the unique combination of proven expertise, best-in-class innovation, and the power of the cloud, presenting a major opportunity for accelerated growth. I am excited to embark on this journey in advancing the industry’s fight against financial crime."


Global AI Market to Reach $40.74 Billion in 2020 – Driven by COVID-Related Demand

A report published by Research and Markets finds that the global AI market will grow from $28.42 billion in 2019 to $40.74 billion in 2020 with a compound annual growth rate (CAGR) of 43.39 percent. According to the report’s summary: “the growth is mainly due to the COVID-19 health emergency across the globe that has led to a new wave of transformative technologies including the revolutionary artificial intelligence technology (for example - smart machines and robots) emerging as a possible solution to contain the epidemic. The market is then expected to recover and reach $99.94 billion in 2023 at CAGR of 34.86%.”

Sam Mowers, Investorideas.com


For a list of artificial intelligence stocks on Investorideas.com visit here or become an Investor Ideas member

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .
The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

Visit the Podcast page at Investorideas.com:

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

Download our Mobile App for iPhone and Android 

Contact Investorideas.com
800 665 0411


Get more Technology stock investor ideas - news, articles, podcasts and stock directories